Bio-IT World | The Accelrys next-generation informatics suite consists of updated existing products and components, but perhaps most noteworthy is the marriage with a cloud-based product called HEOS, in partnership with Scynexis, for externalizing research.
|
January 9, 2012 | Accelrys announced its next-generation informatics suite at its European user group meeting in Athens last year. The suite consists of some updated existing products and some new components, explains Accelrys’ senior director for life science marketing, Rob Brown. Those features include a chemical registration system, a chemical data cartridge, and a cloud-based product called HEOS, in partnership with SCYNEXIS, for externalizing research.
|
Bio-IT World | Accelrys is releasing its "next-generation informatics suite" this week, including a chemical registration system and a Cloud-based portal called HEOS in partnership with SCYNEXIS, in what one company executive calls the first coherent suite to span scientists' daily workflows since the 2010 merger with Symyx.
|
Bio-IT World | Accelrys and Symyx Technologies have announced that the two informatics companies will merge in an all-stock deal expected to close by June 2010. The name of the new company has not yet been announced.
|
New Software for HTS DISCOVERY TOOLS · A Columbia LIMS named SLIMS picks old drug for new disease BY MARK D. UEHLING Spinal muscular atrophy (SMA) is the type of disease you wish you'd never heard of. The industrial world's leading genetic disease killing infants under age two, SMA is a
|
2007 MDL acquisition fuels claims of market leadership. By Kevin Davies Feb. 1, 2008 | The dust is still settling on Symyx Software’s acquisition last October of MDL Information Systems, but the company believes the merger has made it the undisputed market leader in life sciences software. Timothy Campbell,
|
Nov. 13, 2007 | Rudolph Potenzone has a string of familiar software companies on his resume — the former president and CEO of LION bioscience has also worked for informatics companies such as MDL, Chemical Abstracts Service (CAS), and more recently, Ingenuity, and CambridgeSoft. But his latest employer is the
|
More than 40 years after beta blockers were first used clinically, scientists can finally get a close-up look at the drugs' molecular target-the β 2 -adrenergic receptor. The work, supported by by two major initiatives of the National Institutes of Health -- the Roadmap and the Protein Structure Initiative --
|
In its third quarter report issued last week, Symyx Technologies announced it would lay off 124 employees as part of a restructuring plan following on the heels of its acquisition of MDL. The layoffs will “reduce overlap and streamline corporate operations,” according to a company statement . The staff reduction is
|
NewsWeek | Last week, Symyx Technologies acquired MDL Information Systems from Elsevier
|
Sept. 13, 2007 | Symyx Technologies has acquired MDL Information Systems from Elsevier in a $123 million, all-cash transaction. For Symyx, the acquisition is consistent with company’s ongoing efforts to drive shareholder value. “When I was first exposed to [MDL product] Isentris, I thought, we have to have
|
Tuesday, August 21, 2007 | Bio-ITWorld.com | Archives | Advertising | Your Account | CHI Conferences | Subscribe |
|
Last week, Symyx Technologies acquired MDL Information Systems from Elsevier in a $123 million, all-cash transaction. For Symyx, the acquisition is consistent with the company’s ongoing efforts to drive shareholder value. “When I was first exposed to [MDL's] Isentris [informatics system], I thought, ‘We have
|
Symyx Technologies Inc . today announced it has entered into a definitive agreement to acquire certain content and software products of MDL Information Systems for $123 million in cash (subject to a working capital adjustment) from Elsevier Inc. Through this acquisition, Symyx will become a leader in R&D
|
Rosetta Genomics has signed a research agreement with Columbia University Medical Center to advance its lead cancer diagnostic. Under the terms of the agreement, Columbia University Medical Center will utilize its Clinical Laboratory Improvement Amendments (CLIA) certified laboratory to perform clinical validation
|
April 12, 2007 | Medicinal chemistry is fast evolving from an "art" to a "science." Driven by advances in chemical synthesis, instrumentation, and high-throughput and high-content screening technology, this transition is also benefiting from a wealth of new software products, spanning both bio- and cheminformatics.
|
March 12, 2007 | Five years ago, the inaugural issue of Bio•IT World featured a series of introductory interviews with the key executives and evangelists of 60 companies, enabling industry legends and rookie entrepreneurs alike to share their views on the bio-IT industry (see Champions of Bio-IT , March 2002).
|
March 12, 2007 Spotfire Christopher Ahlberg Founder & CEO How has your company adapted and responded to the changing economic climate in the past five years when so many others companies did not? The past five years have been years of rapid growth for Spotfire, in large part because pharmaceutical
|
March 12, 2007 Elsevier MDL Lars Barfod President & CEO How has your company adapted and responded to the changing economic climate in the past five years when so many others companies did not? Elsevier MDL delivers informatics solutions with real business value rather than just technology clout. The
|
March 12, 2007 | Five years ago, the inaugural issue of Bio•IT World featured a series of introductory interviews with the key executives and evangelists of 60 companies, enabling industry legends and rookie entrepreneurs alike to share their views on the bio-IT industry (see Champions of Bio-IT , March 2002). T
|